Print Friendly, PDF & Email

NCT/Study#

NCT03651128 /

BB2121-MM-003

A Phase 3, Multicenter, Randomized, Open Label Study To Compare The Efficacy And Safety Of Bb2121 Versus Standard Triplet Regimens In Subjects With Relapsed And Refractory Multiple Myeloma

DISEASE GROUP:
Multiple Myeloma
current phase:
Phase III
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: